Skip to main content
. 2018 Feb 1;41(3):zsy005. doi: 10.1093/sleep/zsy005

Table 1.

Characteristics of study participants at follow-up II interview by change in sleep duration from baseline (1993–1998) to follow-up II (2006–2010), the Singapore Chinese Health Study

Change in sleep duration P*
Baseline Short (≤5 hr) Recommended (7 hr) Long (≥9 hr)
Follow-up II Short 7 hr Long Short 7 hr Long Short 7 hr Long
N 1054 701 618 1104 3659 2885 114 334 1085
Age, years 68.8 ± 7.7 69.2 ± 7.3 73.4 ± 7.7 67.6 ± 7.2 66.2 ± 6.7 70.7 ± 7.5 70.3 ± 9.0 66.5 ± 6.7 71.0 ± 7.7 <0.001
Body mass index, kg/m2 23.1 ± 3.6 23.2 ± 3.6 23.1 ± 3.5 23.3 ± 3.6 23.2 ± 3.3 23.3 ± 3.6 23.1 ± 4.0 23.1 ± 3.7 23.1 ± 3.6 0.73
Men 374 (35.5) 235 (33.5) 210 (34.0) 411 (37.2) 1580 (43.2) 1190 (41.3) 46 (40.4) 125 (37.4) 443 (40.8) <0.001
Dialect group <0.001
 Cantonese 512 (48.6) 379 (54.1) 327 (52.9) 465 (42.1) 1880 (51.4) 1396 (48.4) 54 (47.4) 172 (51.5) 568 (52.4)
 Hokkien 542 (51.4) 322 (45.9) 291 (47.1) 639 (57.9) 1779 (48.6) 1489 (51.6) 60 (52.6) 162 (48.5) 517 (47.7)
Moderate of vigorous physical activity, hr/week <0.001
 <0.5 91 (8.6) 57 (8.1) 110 (17.8) 73 (6.6) 249 (6.8) 365 (12.7) 17 (14.9) 31 (9.3) 168 (15.5)
 0.5–4 127 (12.1) 77 (11.0) 128 (20.7) 165 (15.0) 559 (15.3) 555 (19.2) 21 (18.4) 51 (15.3) 193 (17.8)
 ≥4 836 (79.3) 567 (80.9) 380 (61.5) 866 (78.4) 2851 (77.9) 1965 (68.1) 76 (66.7) 252 (75.5) 724 (66.7)
Level of education <0.001
 No formal education 286 (27.1) 225 (32.1) 251 (40.6) 285 (25.8) 670 (18.3) 902 (31.3) 38 (33.3) 70 (21.0) 335 (30.9)
 Primary school 473 (44.9) 308 (43.9) 285 (46.1) 482 (43.7) 1580 (43.2) 1368 (47.4) 53 (46.5) 152 (45.5) 511 (47.1)
 Secondary school or higher 295 (28.0) 168 (24.0) 82 (13.3) 337 (30.5) 1409 (38.5) 615 (21.3) 23 (20.2) 112 (33.5) 239 (22.0)
Smoking status <0.001
 Never 772 (73.2) 504 (71.9) 422 (68.3) 800 (72.5) 2673 (73.1) 1956 (67.8) 80 (70.2) 240 (71.9) 708 (65.3)
 Former 177 (16.8) 107 (15.3) 132 (21.4) 180 (16.3) 594 (16.2) 575 (19.9) 17 (14.9) 60 (18.0) 215 (19.8)
 Current 105 (10.0) 90 (12.8) 64 (10.4) 124 (11.2) 392 (10.7) 354 (12.3) 17 (14.9) 34 (10.2) 162 (14.9)
Alcohol intake <0.001
 None 967 (91.8) 642 (91.6) 579 (93.7) 1029 (93.2) 3298 (90.1) 2682 (93.0) 104 (91.2) 300 (89.8) 981 (90.4)
 Weekly 57 (5.4) 46 (6.6) 20 (3.2) 52 (4.7) 278 (7.6) 132 (4.6) 7 (6.1) 24 (7.2) 64 (5.9)
 Daily 30 (2.9) 13 (1.9) 19 (3.1) 23 (2.1) 83 (2.3) 71 (2.5) 3 (2.6) 10 (3.0) 40 (3.7)
Comorbidities
 Hypertension 568 (53.9) 378 (53.9) 404 (65.4) 608 (55.1) 1902 (52.0) 1701 (59.0) 69 (60.5) 185 (55.4) 637 (58.7) <0.001
 Ischaemic heart disease 98 (9.3) 45 (6.4) 62 (10.0) 78 (7.1) 187 (5.1) 251 (8.7) 12 (10.5) 25 (7.5) 76 (7.0) <0.001
 Stroke 48 (4.6) 26 (3.7) 55 (8.9) 53 (4.8) 92 (2.5) 202 (7.0) 8 (7.0) 15 (4.5) 69 (6.4) <0.001
 Diabetes 238 (22.6) 144 (20.5) 169 (27.4) 231 (20.9) 632 (17.3) 697 (24.2) 29 (25.4) 75 (22.5) 298 (27.5) <0.001
 Cancer 92 (8.7) 47 (6.7) 60 (9.7) 93 (8.4) 227 (6.2) 269 (9.3) 12 (10.5) 31 (9.3) 88 (8.1) <0.001

*p-Value by ANOVA (continuous variables) or χ2-test (categorical variables).